Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A01667-38 | Other Identifier | ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sickle cell disease (or sickle cell anemia) is the most common genetic disease in France with 586 children screened in 2019. This chronic disease is characterized by the presence of abnormal Hemoglobin (Hb) S and a deformation of the red blood cells which take the elongated shape of a sickle and become more rigid and more fragile. Sickle cell disease manifests itself among other things by very painful vaso-occlusive crises (VOC) and for some chronic pain.
Their management is an emergency and often requires hospitalization. Despite analgesic treatment, some patients have persistent pain.
In 2013, a childcare assistant trained in Canadian global reflexology EMC offered reflexology sessions to 12 sickle cell patients. She observed a relief in all patients with a decrease in the pain score in 8 of them. These sessions seem to show us a double interest: the reduction of the child's pain and the emergence of a technique that can be used by paramedics in the context of their own role.
The investgators hypothesize that global reflexology is an effective and acceptable complementary technique for pain management in addition to the usual analgesic management in sickle cell children under 18 years of age in CVO. In order to verify our hypothesis, the investigators propose to explore the practice of Canadian global reflexology as an innovative therapeutic option complementary to drug treatments in the hospital management of sickle cell children.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| global reflexology | Other | This study involves subjects under 18 years of age, suffering from sickle cell disease, hospitalized in the short-stay hospitalization unit (UHCD) or continuous monitoring unit (USC) of the Women's Mother and Child Hospital of the Hospices Civils de Lyon. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Global reflexology | Other | The EMC method is a global reflexology technique inspired by the work of the American naturopath Stanley Burrough (Vitaflex, 1976). It is a method of reflexology on the whole body, of acupressure massages (rhythmic and targeted movements) on so-called "reflex" zones which is practiced on different areas of the body (feet, hands, arms, legs, collarbone, ear) and allows the stimulation of all systems. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain score T20 with the Face Legs Activity Cry Consolability scale | Evolution of pain scores (Face Legs Activity Cry Consolability - FLACC according to the child's age) T0 and T20 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the FLACC pain scale | 20 minutes after the start of the session |
| Pain score T20 with the Visual Analog Scale | Evolution of pain scores (VAS - Visual Analog Scale according to the child's age) T0 and T20 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the VAS pain scale | 20 minutes after the start of the session |
| Measure | Description | Time Frame |
|---|---|---|
| Pain score T80 with the Visual Analog Scale | Changes in pain scores (VAS - Visual Analog Scale according to the child's age) at each session between T0 and T80 minutes after the start of the session. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the VAS pain scale | 80 MINUTES after the start of the session |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| COLLOT Sophie | Contact | 0033472115165 | sophie.collot@chu-lyon.fr | |
| HAESEBAERT Julie, MD | Contact | 0033472115165 | julie.haesebaert01@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| COLLOT SOPHIE | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Femme Mère Enfant | Recruiting | Bron | 69500 | France |
Not provided
| ID | Term |
|---|---|
| D000755 | Anemia, Sickle Cell |
| D010146 | Pain |
| ID | Term |
|---|---|
| D000745 | Anemia, Hemolytic, Congenital |
| D000743 | Anemia, Hemolytic |
| D000740 | Anemia |
| D006402 | Hematologic Diseases |
Not provided
Not provided
Prospective exploratory study of single-center feasibility. Research involving human subjects 2. This feasibility study will estimate the improvement in pain provided by reflexology, acceptability and feasibility, rate of inclusion.
The research will take place in 2 centers, the short-stay hospitalization unit (UHCD) and the continuous monitoring unit (USC) of the Women's Mother and Child Hospital of the Hospices Civils de Lyon.
This study involves subjects under 18 years of age, suffering from sickle cell disease, hospitalized in the unit UHCD or the unit USC.
Not provided
Not provided
Not provided
Not provided
|
| Pain score T80 with the Face Legs Activity Cry Consolability scale | Changes in pain scores (Face Legs Activity Cry Consolability according to the child's age) at each session between T0 and T80 minutes after the start of the sessionmn. The minimum value is 0 (no pain) and the maximum is 10 (maximum pain). All professionals are trained in the use of the FLACC pain scale | 80 minutes after the start of the session |
| Length of hospitalization | Length of stay of patients included in the study, defined by the time between their entry into the UHCD or USC and their return home. | 1 Month |
| Number of reflexology sessions | Total number of global reflexology sessions performed for each child included in the study. | 1 Month |
| Recorded side effects, complications | Recorded side effects, complications | 1 Month |
| Acceptability of the technique : refusal to participate. | Acceptability of the technique: number of refusals to participate in the protocol during the study. | 25 Months |
| Acceptability of the technique: reason for refusal to participate. | Acceptability of the technique: reasons of refusals to participate in the protocol during the study. | 25 months |
| Acceptability of the technique: interruption of participation. | Acceptability of the technique: number of requests for interruption during the study. | 25 months |
| Acceptability of the technique: reason for interruption of participation | Acceptability of the technique: reasons for discontinuations for requests of interruption during the study. | 25 months |
| Feasibility of the technique | Feasibility of the technique: integration into the management of CVO: number of sessions not performed or interrupted and reasons, duration of sessions. | 25 months |
| Inclusion rate | Monthly inclusion rate in the study, characteristics of the eligible population, included and not included. | 25 months |
| D006425 |
| Hemic and Lymphatic Diseases |
| D006453 | Hemoglobinopathies |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |